VERU INC.
VERU · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Barnette K Gary: Form 4
Insider disclosure · Filed · Report period 13 Aug 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000863894 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VERU on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2916 N. Miami Avenue, Suite 1000, Miami, FL, 33127
- Incorporated in
- WI
- Fiscal year end
- 30 September
- Former names on EDGAR
- FEMALE HEALTH CO (to 01 Aug 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields